A multicenter, Randomised, Open-label, prospective study to estimate the add-on effects of Memantine as Ebixa® Oral pump (solution) on language in moderate to severe Alzheimer’s Disease patients already receiving donepezil (ROMEO-AD)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김희진 | - |
dc.date.accessioned | 2023-04-03T18:05:34Z | - |
dc.date.available | 2023-04-03T18:05:34Z | - |
dc.date.created | 2023-02-11 | - |
dc.date.issued | 2022-12-01 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/183897 | - |
dc.publisher | CTAD | - |
dc.title | A multicenter, Randomised, Open-label, prospective study to estimate the add-on effects of Memantine as Ebixa® Oral pump (solution) on language in moderate to severe Alzheimer’s Disease patients already receiving donepezil (ROMEO-AD) | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | 김희진 | - |
dc.identifier.bibliographicCitation | Clinical trials on Alzheimer's Disease | - |
dc.relation.isPartOf | Clinical trials on Alzheimer's Disease | - |
dc.citation.title | Clinical trials on Alzheimer's Disease | - |
dc.citation.conferencePlace | San Francisco, USA | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.